BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29254212)

  • 1. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX.
    Liu H; Zhou G; Fu X; Cui H; Pu G; Xiao Y; Sun W; Dong X; Zhang L; Cao S; Li G; Wu X; Yang X
    Oncotarget; 2017 Nov; 8(60):101899-101910. PubMed ID: 29254212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
    Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
    BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Jiang H; Hu X; Zhang H; Li W
    Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3.
    Xu Y; Ge Z; Zhang E; Zuo Q; Huang S; Yang N; Wu D; Zhang Y; Chen Y; Xu H; Huang H; Jiang Z; Sun L
    Cell Death Dis; 2017 Oct; 8(10):e3104. PubMed ID: 29022920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
    Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis.
    Zeng B; Ye H; Chen J; Cheng D; Cai C; Chen G; Chen X; Xin H; Tang C; Zeng J
    Oncotarget; 2017 Dec; 8(69):113650-113661. PubMed ID: 29371936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma.
    Xu Y; Leng K; Li Z; Zhang F; Zhong X; Kang P; Jiang X; Cui Y
    Oncotarget; 2017 Sep; 8(39):65823-65835. PubMed ID: 29029475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis.
    Zhu J; Shi H; Liu H; Wang X; Li F
    Oncotarget; 2017 Sep; 8(39):65253-65264. PubMed ID: 29029428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD.
    Tang W; Shen Z; Guo J; Sun S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2951-2964. PubMed ID: 27932875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
    Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
    Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2-mediated α-actin methylation needs lncRNA TUG1, and promotes the cortex cytoskeleton formation in VSMCs.
    Chen R; Kong P; Zhang F; Shu YN; Nie X; Dong LH; Lin YL; Xie XL; Zhao LL; Zhang XJ; Han M
    Gene; 2017 Jun; 616():52-57. PubMed ID: 28344045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition.
    Kuang D; Zhang X; Hua S; Dong W; Li Z
    Exp Mol Pathol; 2016 Oct; 101(2):267-273. PubMed ID: 27693324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of long non-coding RNA TUG1 expression in various cancers: a meta-analysis.
    Zhou Y; Lu Y; Li R; Yan N; Li X; Dai T
    Oncotarget; 2017 Nov; 8(59):100499-100507. PubMed ID: 29245996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological Functions of the lncRNA TUG1.
    Guo C; Qi Y; Qu J; Gai L; Shi Y; Yuan C
    Curr Pharm Des; 2020; 26(6):688-700. PubMed ID: 31880241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
    Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
    Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2.
    Duan W; Nian L; Qiao J; Liu NN
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8211-8218. PubMed ID: 31646551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144.
    Cai H; Xue Y; Wang P; Wang Z; Li Z; Hu Y; Li Z; Shang X; Liu Y
    Oncotarget; 2015 Aug; 6(23):19759-79. PubMed ID: 26078353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long noncoding RNA LINC01207 promotes proliferation of lung adenocarcinoma.
    Wang G; Chen H; Liu J
    Am J Cancer Res; 2015; 5(10):3162-73. PubMed ID: 26693067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.